TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15798293

Group type: EXPERIMENTAL
Intervention: Infinity reference (I)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Linked mastoids (L) reference
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Average (A) reference
Number of subjects: 11

Group type: COMPARATOR
Intervention: M reference
Number of subjects: 11

Group type: COMPARATOR
Intervention: L reference
Number of subjects: 11

Group type: COMPARATOR
Intervention: A reference
Number of subjects: 11
Study: 12560628

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with 0.125 percent bupivocaine and morphine after combined general‐epidural anesthesia
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intravenous patient‐controlled analgesia with morphine after general anesthesia
Number of subjects: 24
Study: 9583845

Group type: EXPERIMENTAL
Intervention: BF+SF group (iron-fortified foods from 4 to 6 months)
Number of subjects: 164

Group type: COMPARATOR
Intervention: EBF group (exclusively breast-fed until 6 months)
Number of subjects: 164
Study: 8565975

Group type: EXPERIMENTAL
Intervention: Warm underwater water-jet massage (3 times, 20 min each) during treatment week
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control week (no underwater water-jet massage)
Number of subjects: 14
Study: 2168152

Group type: EXPERIMENTAL
Intervention: Drug-resistant mutant [SR2‐410(r)]
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wild-type HRV‐2
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Drug-dependent mutant [SR2‐410(d)]
Number of subjects: 42
Study: 345886

Group type: EXPERIMENTAL
Intervention: Transfer factor
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study: 31338998

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention
Number of subjects: 2361
Study: 27765696

Group type: EXPERIMENTAL
Intervention: Laparoscopic pyeloplasty
Number of subjects: 98

Group type: COMPARATOR
Intervention: Open pyeloplasty
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 98
Study: 25654728

Group type: EXPERIMENTAL
Intervention: rh-endostatin + EC
Number of subjects: 140

Group type: COMPARATOR
Intervention: EC
Number of subjects: 140
Study: 23095977

Group type: EXPERIMENTAL
Intervention: Balloon atrial septostomy (BAS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 21
Study: 20737135

Group type: EXPERIMENTAL
Intervention: Antenatal pelvic floor muscle exercise (PFME)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 300
Study: 19649521

Group type: EXPERIMENTAL
Intervention: Crown S made via Crystaleye spectrophotometer
Number of subjects: 63

Group type: COMPARATOR
Intervention: Crown V made via conventional visual matching
Number of subjects: 63

Group type: COMPARATOR
Intervention: Visual evaluation by patients (Vp)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Visual evaluation by prosthodontists (Vd)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Overall visual evaluation (p and d)
Number of subjects: 63
Study: 16298017

Group type: EXPERIMENTAL
Intervention: Fasting state
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post-meal state
Number of subjects: 0
Study: 14616929

Group type: EXPERIMENTAL
Intervention: L‐NG methylarginine hydrochloride (L‐NMMA:546C88) 6 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Histamine (0.5 microg/kg/min)
Number of subjects: 12
Study: 10928154

Group type: EXPERIMENTAL
Intervention: Complementary immunotherapy with galactoside‐specific lectin from mistletoe (ML‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard oncologic treatment (control group)
Number of subjects: 0
Study: 8959891

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (500 mg) given prior to reperfusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 0
Study: 1541140

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 2991689

Group type: EXPERIMENTAL
Intervention: ACTH4-9 analog (Org2766) 40 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30685963

Group type: EXPERIMENTAL
Intervention: Oral sulfate solution (OSS)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Ascorbic acid plus polyethylene glycol (AA + PEG)
Number of subjects: 173
Study: 30041183

Group type: EXPERIMENTAL
Intervention: LPNYL treatment (energy density of 45 J/cm2, pulse width of 35 ms, spot size of 4 mm, frequency of 1 Hz, 6 treatments with 1-week intervals)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Oral itraconazole (drug group)
Number of subjects: 177
Study: 26771266

Group type: EXPERIMENTAL
Intervention: ETT-first technique
Number of subjects: 160

Group type: COMPARATOR
Intervention: GlideScope-first technique
Number of subjects: 160
Study: 24885388

Group type: EXPERIMENTAL
Intervention: Enriched Group Lifestyle Balance program (GLB) with if-then plans and mental practice
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard Group Lifestyle Balance program (GLB)
Number of subjects: 154
Study: 22420596

Group type: EXPERIMENTAL
Intervention: Allopurinol augmentation
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Allopurinol augmentation (caffeine abstainers)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 20334955

Group type: EXPERIMENTAL
Intervention: hTERT immunochemical detection in adjacent, non-transformed colonic mucosa
Number of subjects: 82

Group type: COMPARATOR
Intervention: hTERT immunochemical detection in non-affected mucosa
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: hTERT mRNA expression in non-affected colorectal mucosa
Number of subjects: 82
Study: 18779477

Group type: EXPERIMENTAL
Intervention: 0.59-mg fluocinolone acetonide implant
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: 2.1-mg fluocinolone acetonide implant
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Implanted eyes (both doses)
Number of subjects: 278
Study: 15310006

Group type: EXPERIMENTAL
Intervention: PCOS patients
Number of subjects: 27
Study: 11502317

Group type: EXPERIMENTAL
Intervention: Sulfadoxine/pyrimethamine (25 mg/kg sulfadoxine, 1.25 mg/kg pyrimethamine) plus placebo
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Amodiaquine (25 mg/kg) plus placebo
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Amodiaquine plus sulfadoxine/pyrimethamine
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Amodiaquine/sulfadoxine/pyrimethamine
Number of subjects: 445
Study: 9430329

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 64
Study: 8489974

Group type: EXPERIMENTAL
Intervention: 3 ml plain bupivacaine 0.5% injected as fast as possible
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3 ml plain bupivacaine 0.5% injected at a rate of 0.05 ml/sec
Number of subjects: 40
Study: 3427128

Group type: EXPERIMENTAL
Intervention: EMG biofeedback with high success feedback
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: EMG biofeedback with low success feedback
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: True EMG biofeedback
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: False EMG biofeedback
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Self-monitoring study habits
Number of subjects: 47
Study: 29679694

Group type: EXPERIMENTAL
Intervention: Rapid Response System (RRS) intervention comprising a standardised observation and communication protocol including a pragmatic medical response strategy.
Number of subjects: 69356
Study: 27376184

Group type: EXPERIMENTAL
Intervention: Arthrocentesis plus corticosteroid (CS) injection
Number of subjects: 24

Group type: COMPARATOR
Intervention: Arthrocentesis alone (control group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Comparison between CS group and control group
Number of subjects: 24
Study: 24548730

Group type: EXPERIMENTAL
Intervention: 0.5% levobupivicaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% normal saline (placebo)
Number of subjects: 60
Study: 22393908

Group type: EXPERIMENTAL
Intervention: Calfactant aerosol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline aerosol
Number of subjects: 8
Study: 20828359

Group type: EXPERIMENTAL
Intervention: 15 cm² rivastigmine patch (13.3 mg/24 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5 cm² rivastigmine patch (4.5 mg/24 h)
Number of subjects: 0
Study: 19040348

Group type: EXPERIMENTAL
Intervention: Nepafenac 0.1% QD
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Nepafenac 0.1% BID
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Nepafenac 0.1% TID
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 16875901

Group type: EXPERIMENTAL
Intervention: Controlled-release metoprolol
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10000
Study: 12804031

Group type: EXPERIMENTAL
Intervention: Door-in-the-face (DITF) technique: subjects were first solicited by an exaggerated request and then for a small donation after refusal.
Number of subjects: 1607

Group type: COMPARATOR
Intervention: Control condition: direct solicitation for a small donation without prior exaggerated request.
Number of subjects: 1607
Study: 10870801

Group type: EXPERIMENTAL
Intervention: 75 mg aspirin (daily for 1 week)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 300 mg aspirin (daily for 1 week)
Number of subjects: 18
Study: 8784646

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study: 1641433

Group type: EXPERIMENTAL
Intervention: In-home educational intervention conducted by lay health workers (LHWs) on three occasions; education on cancer and reproductive health.
Number of subjects: 321

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 321
Study: 6697460

Group type: EXPERIMENTAL
Intervention: 1 J truncated exponential shocks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 5 J truncated exponential shocks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 10 J truncated exponential shocks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 25 J truncated exponential shocks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 1 J to 25 J shocks
Number of subjects: 33
Study: 31353695

Group type: EXPERIMENTAL
Intervention: Ora-pro-nobis (Pereskia aculeata) flour
Number of subjects: 0
Study: 29644920

Group type: EXPERIMENTAL
Intervention: Independent Medical Evaluation (IME)
Number of subjects: 9
Study: 26962518

Group type: COMPARATOR
Intervention: Full time neutral wrist splint (Group A)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 40 mg Depo‐Medrol injection plus full time neutral wrist splint (Group B)
Number of subjects: 43
Study: 24460811

Group type: EXPERIMENTAL
Intervention: Mask ventilation with chest compressions
Number of subjects: 58
Study: 22806147

Group type: EXPERIMENTAL
Intervention: Island flap (IF group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bilobed flap (BF group)
Number of subjects: 120
Study: 20663187

Group type: EXPERIMENTAL
Intervention: Dextrose 75 g (300 kcals)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Dextrose 150 g (600 kcals)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lipid 33 g (300 kcals)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lipid 66 g (600 kcals)
Number of subjects: 9
Study: 17484344

Group type: EXPERIMENTAL
Intervention: promethazine (25 mg) + caffeine (200 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: meclizine (25 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Scopolamine patch (1.5 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: acustimulation wristband
Number of subjects: 64
Study: 15218043

Group type: EXPERIMENTAL
Intervention: Porphyromonas gingivalis LPS stimulation
Number of subjects: 0
Study: 16052902

Group type: EXPERIMENTAL
Intervention: Recruitment process developed for a randomized controlled trial with adolescents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nurse clinicians' involvement in recruitment
Number of subjects: 0
Study: 9775517

Group type: EXPERIMENTAL
Intervention: Motor rotation compatible with mental rotation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motor rotation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motor rotation speed
Number of subjects: 0
Study: 7944997

Group type: EXPERIMENTAL
Intervention: Diltiazem (180 mg tid for 6 months)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 2908751

Group type: EXPERIMENTAL
Intervention: Roxatidine acetate 75 mg twice daily
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Roxatidine acetate 150 mg at bedtime
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Roxatidine acetate 150 mg post cenam nocte
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Roxatidine acetate 300 mg post cenam nocte
Number of subjects: 59

Group type: COMPARATOR
Intervention: Ranitidine 300 mg nocte
Number of subjects: 59

Group type: COMPARATOR
Intervention: Ranitidine 300 mg post cenam nocte
Number of subjects: 59
Study: 31941792

Group type: EXPERIMENTAL
Intervention: Double-injection costoclavicular block
Number of subjects: 90

Group type: COMPARATOR
Intervention: Single-injection costoclavicular block
Number of subjects: 90
Study: 29260659

Group type: EXPERIMENTAL
Intervention: Enhanced coverage (90% target)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard coverage (80% target)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups (Enhanced and Standard coverage)
Number of subjects: 24
Study: 27676152

Group type: EXPERIMENTAL
Intervention: Dynamic stretching (four 30-s periods of ankle dorsiflexion and plantarflexion)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dynamic stretching
Number of subjects: 12
Study: 24699712

Group type: EXPERIMENTAL
Intervention: Well Woman Exam (WWE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Intervention (SI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Four Educational Sessions (4ES)
Number of subjects: 0
Study: 23737646

Group type: EXPERIMENTAL
Intervention: Immunotherapy (not explicitly detailed in the abstract)
Number of subjects: 59
Study: 20649936

Group type: EXPERIMENTAL
Intervention: Mirodenafil 100 mg
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 19068007

Group type: EXPERIMENTAL
Intervention: Individual Cognitive Behavioral Treatment (IT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioral Treatment (GT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Individual and Group CBT
Number of subjects: 38
Study: 16912128

Group type: EXPERIMENTAL
Intervention: sitagliptin 25 mg
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: sitagliptin 200 mg
Number of subjects: 58

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 58
Study: 12388137

Group type: EXPERIMENTAL
Intervention: 50 mg oxymetholone daily for 12 weeks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 100 mg oxymetholone daily for 12 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 14748774

Group type: EXPERIMENTAL
Intervention: Eletriptan 40 mg
Number of subjects: 1132
Study: 9990641

Group type: EXPERIMENTAL
Intervention: Hot Can 1743
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cold Can 1741
Number of subjects: 40
Study: 7492458

Group type: EXPERIMENTAL
Intervention: 1 litre of beverage containing 50 g alcohol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 8
Study: 1969509

Group type: EXPERIMENTAL
Intervention: Vitamin and mineral supplementation for seven months
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 86
Study: 7420129

Group type: EXPERIMENTAL
Intervention: Punctate hot stimulator (1 mm²)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Punctate cold stimulator (1 mm²)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thermal stimulators (enlarged contact area)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hot stimulator (enlarged area)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cold stimulator (enlarged area)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated recognition of stimulators
Number of subjects: 0
Study: 28000678

Group type: EXPERIMENTAL
Intervention: prebiotics (scGOS/lcFOS/glutamine)
Number of subjects: 44

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 44
Study: 25480319

Group type: EXPERIMENTAL
Intervention: Paravertebral analgesia with propofol GA (PPA)
Number of subjects: 386
Study: 24053566

Group type: EXPERIMENTAL
Intervention: Happiness Route
Number of subjects: 256

Group type: COMPARATOR
Intervention: Customized Care (Control)
Number of subjects: 256
Study: 21854580

Group type: EXPERIMENTAL
Intervention: Oral topiramate (n = 36) as an add-on to cognitive behavioural therapy (CBT)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Oral modafinil (n = 36) as an add-on to cognitive behavioural therapy (CBT)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Oral dexamphetamine sustained-release (n = 36) as an add-on to cognitive behavioural therapy (CBT)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Cognitive behavioural therapy (CBT) only (controls: n = 3 × 36)
Number of subjects: 216
Study: 19250078

Group type: EXPERIMENTAL
Intervention: Gold-tip ablation catheter (group G)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Platinum-iridium tip catheter (group PI)
Number of subjects: 31
Study: 17915468

Group type: EXPERIMENTAL
Intervention: Combination of halotherapy (HT) and endobronchial helium‐neon laser irradiation (ELI) with traditional drug therapy (DT) in moderate persistent asthma
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Multimodality treatment involving DT, HT, and ELI in severe persistent asthma
Number of subjects: 138
Study: 15528779

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise program (45 minutes, 3 times a week for 8 weeks)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise program
Number of subjects: 294

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 294
Study: 11677365

Group type: EXPERIMENTAL
Intervention: Angiotensin(1-7) (1000 pmol/min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Angiotensin(1-7) (100 pmol/min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Angiotensin(1-7) (10 pmol/min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: NG-mononmethyl-l-arginine (co-infused with Ang(1-7))
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Acetylcholine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside
Number of subjects: 16
Study: 9043043

Group type: EXPERIMENTAL
Intervention: T2-weighted and dynamic contrast enhanced MRI
Number of subjects: 32

Group type: COMPARATOR
Intervention: Contrast enhanced CT
Number of subjects: 32
Study: 7966508

Group type: EXPERIMENTAL
Intervention: Addiction Severity Index (ASI) scores
Number of subjects: 0
Study: 3286722

Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 1 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 2 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 5 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 10 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 20 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 10 mg (exercise challenge)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inhaled gallopamil 1 mg (exercise challenge)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (exercise challenge)
Number of subjects: 11
Study: 31624975

Group type: EXPERIMENTAL
Intervention: Spectral-domain optical coherence tomography (SD-OCT)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Multifocal visual evoked potentials (mfVEP)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Mean inter-eye asymmetry of the RNFLt
Number of subjects: 33
Study: 30202872

Group type: EXPERIMENTAL
Intervention: Intensive MDA (quarterly single-dose praziquantel plus albendazole daily for 3 days)
Number of subjects: 3350

Group type: COMPARATOR
Intervention: Standard MDA (annual praziquantel plus 6 monthly single-dose albendazole)
Number of subjects: 3350
Study: 29043996

Group type: EXPERIMENTAL
Intervention: rhBNP and dopamine combination treatment
Number of subjects: 160

Group type: COMPARATOR
Intervention: Dopamine
Number of subjects: 160
Study: 26189942

Group type: EXPERIMENTAL
Intervention: CLEAR CARE(®)
Number of subjects: 74

Group type: COMPARATOR
Intervention: renu(®) fresh™
Number of subjects: 74
Study: 23011358

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg BIW
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Etanercept 10 mg BIW
Number of subjects: 550

Group type: COMPARATOR
Intervention: Methotrexate (≤8.0 mg/week)
Number of subjects: 550
Study: 21305484

Group type: EXPERIMENTAL
Intervention: Strength exercises without electrostimulation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Strength exercises with electrostimulation
Number of subjects: 10
Study: 19133409

Group type: EXPERIMENTAL
Intervention: Omega-3 PUFAs supplementation (2.4 g/day for 24 weeks)
Number of subjects: 1533
Study: 17212730

Group type: EXPERIMENTAL
Intervention: Prednisolone 2 mg kg(‐1) day(‐1) for 2 days (six doses)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 15379836

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori-infected GERD patients
Number of subjects: 101

Group type: COMPARATOR
Intervention: Helicobacter pylori-non-infected GERD patients
Number of subjects: 101
Study: 12057618

Group type: EXPERIMENTAL
Intervention: HBsAg/AS04 hepatitis B vaccine (administered on a 0 and 6 months schedule)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Licensed hepatitis B vaccine (Engerix-B, administered on a 0, 1 and 6 months schedule)
Number of subjects: 230
Study: 9839765

Group type: EXPERIMENTAL
Intervention: Donepezil HCl (5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Digoxin (0.25 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of donepezil HCl (5 mg) and digoxin (0.25 mg)
Number of subjects: 12
Study: 7651638

Group type: EXPERIMENTAL
Intervention: Interceed (TC7) Absorbable Adhesion Barrier
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (untreated ovaries)
Number of subjects: 55